C

CytoTools AG
XETRA:T5O

Watchlist Manager
CytoTools AG
XETRA:T5O
Watchlist
Price: 101.26 EUR 0.98% Market Closed
Market Cap: 52.8m EUR
Have any thoughts about
CytoTools AG?
Write Note

Wall Street
Price Targets

T5O Price Targets Summary
CytoTools AG

Wall Street analysts forecast T5O stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for T5O is 25.93 EUR with a low forecast of 25.68 EUR and a high forecast of 26.7 EUR.

Lowest
Price Target
25.68 EUR
75% Downside
Average
Price Target
25.93 EUR
74% Downside
Highest
Price Target
26.7 EUR
74% Downside
CytoTools AG Competitors:
Price Targets
KRRO
Korro Bio Inc
146% Upside
CAPR
Capricor Therapeutics Inc
116% Upside
VITR
Vitrolife AB
23% Upside
4593
Healios KK
91% Upside
RPTX
Repare Therapeutics Inc
325% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
15% Upside
OXB
Oxford BioMedica PLC
25% Upside
INCY
Incyte Corp
10% Upside

Revenue
Forecast

Revenue Estimate
CytoTools AG

For the last 9 years the compound annual growth rate for CytoTools AG's revenue is -14%. The projected CAGR for the next 1 year is 24%.

-14%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-91%
Average Miss

Operating Income
Forecast

Operating Income Estimate
CytoTools AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss

Net Income
Forecast

Net Income Estimate
CytoTools AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is T5O's stock price target?
Price Target
25.93 EUR

According to Wall Street analysts, the average 1-year price target for T5O is 25.93 EUR with a low forecast of 25.68 EUR and a high forecast of 26.7 EUR.

What is CytoTools AG's Revenue forecast?
Projected CAGR
24%

For the last 9 years the compound annual growth rate for CytoTools AG's revenue is -14%. The projected CAGR for the next 1 year is 24%.

Back to Top